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Crystal structure determination of biological macromolecules using the novel
technique of serial femtosecond crystallography (SFX) is severely limited by
the scarcity of X-ray free-electron laser (XFEL) sources. However, recent and
future upgrades render microfocus beamlines at synchrotron-radiation sources
suitable for room-temperature serial crystallography data collection also. Owing
to the longer exposure times that are needed at synchrotrons, serial data
collection is termed serial millisecond crystallography (SMX). As a result, the
number of SMX experiments is growing rapidly, with a dozen experiments
reported so far. Here, the first high-viscosity injector-based SMX experiments
carried out at a US synchrotron source, the Advanced Photon Source (APS), are
reported. Microcrystals (5–20 mm) of a wide variety of proteins, including
lysozyme, thaumatin, phycocyanin, the human A2A adenosine receptor
(A2AAR), the soluble fragment of the membrane lipoprotein Flpp3 and
proteinase K, were screened. Crystals suspended in lipidic cubic phase (LCP)
or a high-molecular-weight poly(ethylene oxide) (PEO; molecular weight
8 000 000) were delivered to the beam using a high-viscosity injector. In-house
data-reduction (hit-finding) software developed at APS as well as the SFX data-
reduction and analysis software suites Cheetah and CrystFEL enabled efficient
on-site SMX data monitoring, reduction and processing. Complete data sets
were collected for A2AAR, phycocyanin, Flpp3, proteinase K and lysozyme, and
the structures of A2AAR, phycocyanin, proteinase K and lysozyme were
determined at 3.2, 3.1, 2.65 and 2.05 A˚ resolution, respectively. The data
demonstrate the feasibility of serial millisecond crystallography from 5–20 mm
crystals using a high-viscosity injector at APS. The resolution of the crystal
structures obtained in this study was dictated by the current flux density and
crystal size, but upcoming developments in beamline optics and the planned
APS-U upgrade will increase the intensity by two orders of magnitude. These
developments will enable structure determination from smaller and/or weakly
diffracting microcrystals.
1. Introduction
Despite the deposition of over 115 000 crystal structures of
biological macromolecules in the Protein Data Bank (PDB;
http://www.rcsb.org), traditional techniques of macro-
molecular X-ray crystallography have always suffered from
two major bottlenecks: the production of large, well diffracting
crystals and radiation damage. The former has been especially
prevalent in the structure determination of membrane
proteins and large complexes, which can require months or
even years of devoted effort to optimize conditions for the
growth of crystals of sufficient quality, while the latter has
hindered progress in the structural determination of radiation-
sensitive proteins. For decades, the effect of radiation damage
in macromolecular crystallography has been addressed by
cryocooling crystals (Low et al., 1966; Macchi, 2012; Pflugrath,
2004), thus extending their lifetime during X-ray beam
exposure. However, third-generation synchrotrons produce
such intense microfocus X-ray beams that rapid photo-
damage can rapidly accumulate even under cryogenic condi-
tions (Ravelli & Garman, 2006). Both the crystal-size and
radiation-damage limitations have now been overcome by
X-ray free-electron lasers (XFELs), the brightest X-ray
sources, which are capable of producing extremely intense
femtosecond X-ray pulses. Taking advantage of these unique
properties, a new method of crystallography has emerged,
termed serial femtosecond crystallography (SFX; Chapman et
al., 2011). In SFX, hundreds of thousands of nanocrystals and
microcrystals suspended in their mother liquor or in a viscous
carrier are delivered to the X-ray beam in a jet. The duration
of exposure per crystal is so short (typically 40 fs) that
diffraction can be recorded by a fast, integrating detector
before the beam destroys the crystal, thereby outrunning
radiation damage (Chapman et al., 2011; Neutze et al., 2000).
The high intensity of the XFEL pulses used in SFX eliminates
the need to grow large crystals. Inspired by this novel
methodology, a number of innovations such as nanocrystalli-
zation and microcrystallization techniques (Kupitz et al., 2014;
Liu et al., 2014; Redecke et al., 2013), serial sample-delivery
methods (Ayvazyan et al., 2006; Feld et al., 2015; Huang et al.,
2015; Sierra et al., 2012; Weierstall et al., 2012, 2014), fast-
readout detector technology (e.g. CSPAD) and rapid, high-
throughput data-reduction and data-processing software have
been developed (Barty et al., 2014; Kirian et al., 2010, 2011;
Sauter, 2015; Sawaya et al., 2014; White et al., 2012, 2013,
2016). Consequently, numerous SFX crystal structures of
membrane and soluble proteins have now been solved and
deposited in the PDB (for a review, see Martin-Garcia et al.,
2016), showing the increasing utility of this technology to
structural biologists.
Despite the advantages mentioned above, the use of SFX is
severely limited by the scarcity of XFEL facilities. Currently,
only two XFELs are operational in the world: the Linac
Coherent Light Source (LCLS) at the SLAC National
Accelerator Laboratory, Stanford, California, USA and the
SPring-8 Angstrom Compact Free-Electron Laser (SACLA)
in Japan. Unlike synchrotrons, the circular design of which
allows the placement of many beamlines around the storage
ring, XFELs are limited to only a few beamlines, only one of
which can collect diffraction data at any given time, owing to
their linear design. Even though several XFEL sources are
currently under construction (PAL in South Korea, SwissFEL
in Switzerland and the European XFEL in Germany) and are
expected to enter the commissioning phase in 2017, the total
number of XFELs will still be too low to meet the growing
needs of the structural biology community compared with the
numerous synchrotron facilities currently available worldwide
(over 30 synchrotrons; http://www.esrf.eu/UsersAndScience/
Links/Synchrotrons). To overcome this limitation, the struc-
tural biology community has begun to adopt the serial
crystallography approach at the microfocus beamlines of
third-generation synchrotron-radiation sources, which
produce bright micrometre-sized X-ray beams and are
equipped with fast-readout detectors (e.g. PILATUS and
EIGER). However, since the brilliance of synchrotrons is not
as high as that of XFELs, at least a millisecond exposure is
required to produce sufficiently strong diffraction. Here, the
microcrystals are delivered either loaded into fixed-target
devices or continuously in single file across the beam in a
viscous host medium. Because a goniometer is not used, a
sufficiently viscous medium is important to prevent significant
rotation of the crystals during exposure. The change in
diffraction conditions is therefore negligible if the rotational
diffusion time of the crystal in the medium is much longer than
the exposure time. Thus, this method has been named serial
millisecond crystallography (SMX). Over the last three years,
several SMX trials have been published (Botha et al., 2015;
Coquelle et al., 2015; Gati et al., 2014; Hasegawa et al., 2016;
Heymann et al., 2014; Huang et al., 2015, 2016; Murray et al.,
2015; Nogly et al., 2015; Stellato et al., 2014; Zander et al.,
2015).
One of the major concerns in adopting the serial approach
at synchrotrons was radiation damage. It has been reported
that 0.3 MGy is the radiation-dose limit beyond which the
information collected from a single crystal at room tempera-
ture is compromised (Nave & Garman, 2005). At XFELs, the
pulse duration (femtoseconds) is sufficiently short such that
the effects of radiation damage can be mitigated. An XFEL
femtosecond pulse leads to photo-ionization of the inner core
shell electrons, producing ‘hollow atoms’, in less than 10 fs
(Hau-Riege & Bennion, 2015). Molecules are then destroyed
by Coulomb explosion, which terminates diffraction before
secondary radiation damage can take place. For this reason,
even though XFELs produce extremely brilliant X-rays, SFX
data show sufficiently reduced radiation damage to allow the
collection of data at doses in excess of 3 GGy (Lomb et al.,
2011), which is over 10 000 times the estimated tolerable dose
at room temperature (Nave & Garman, 2005). At synchrotron
sources, the low monochromatic photon flux along with the
quasi-continuous beam-operation mode lead to an exposure
timescale per crystal/image in the millisecond range, which is
not fast enough to outrun primary damage. Here, secondary
radiation damage plays a major role as free radicals reduce
molecules, leading to the breakage of chemical bonds, which
finally destroys the molecules and weakens crystal contacts on
much longer timescales than the Coulomb explosion observed
with XFEL femtosecond pulses. However, a recent study has
demonstrated that for the same total dose, secondary radia-
tion damage owing to diffusion of free radicals can be reduced
by increasing the intensity and inversely decreasing the
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exposure time (Owen et al., 2012). Another factor that has
contributed to the success of SMX at synchrotrons is the
recent improvement in sample-delivery methods (for example
the high-viscosity injector), and the high efficiency achieved
with fast-readout detectors that can collect data in a shutter-
less mode. High-viscosity injectors require reduced sample
volumes compared with liquid injectors (for example the gas
dynamic virtual nozzle; GDVN; Weierstall et al., 2014). In
addition, fast-flowing liquid injectors are impractical for SMX
experiments because the crystal transit time across the beam
would be in the submillisecond range and thus the crystal
would not be exposed to sufficient flux to diffract strongly. A
large variety of sample-delivery methods have been success-
fully applied, including delivering crystals by flowing them
through capillaries (Stellato et al., 2014), high-viscosity injec-
tors (Botha et al., 2015; Nogly et al., 2015) and novel fixed-
target systems (Coquelle et al., 2015; Gati et al., 2014;
Hasegawa et al., 2016; Huang et al., 2015; Murray et al., 2015).
With the intention of making the serial crystallography
approach more broadly accessible to the structural biology
community, we implemented SMX at the GM/CA 23-ID-D
beamline at the Advanced Photon Source (APS), a third-
generation synchrotron source at Argonne National Labora-
tory, Chicago, Illinois, USA. A set of proteins was chosen
including membrane proteins, soluble proteins and a multi-
protein cofactor complex. The membrane protein was the
human A2A adenosine receptor containing the BRIL fusion
protein in the third intracellular loop (A2AAR). A2AAR is one
of the best-studied human G-protein coupled receptors
(GPCRs) for which a structure has been determined
previously (Batyuk et al., 2016; Liu et al., 2012). The set of
soluble proteins that we tested include Francisella tularensis
SCHUS4 Flpp3 soluble domain, proteinase K, thaumatin and
lysozyme, and the multiprotein cofactor antenna complex
phycocyanin (PC). PC is a cyanobacterial antenna protein that
forms part of the phycobilisome light-harvesting complex,
which channels excitation energy to photosystem II. The PC
complex forms a disk-like trimer in which each monomer is
composed of two subunits,  and  (Schirmer et al., 1985),
where each subunit binds three chromophores. Flpp3 is the
soluble domain of a membrane lipoprotein located in the
outer membrane of F. tularensis, which is the causative agent
of the disease tularemia. Flpp3 has been identified as a viru-
lence determinant (Su et al., 2007), and its atomic resolution
structure has recently been determined by NMR (Zook et al.,
2015); however, a crystallographic structure has not yet been
reported. Proteinase K is a commercially available enzyme
belonging to the family of serine proteases, which has been
used in numerous studies to identify disordered regions in
intrinsically disordered proteins (IDPs; Csizmo´k et al., 2005;
Denning et al., 2003; Marı´n et al., 2012; Martin-Garcia et al.,
2014; Nyarko et al., 2004). Thaumatin and lysozyme were also
included as they crystallize rapidly and easily, and are there-
fore frequently used as model systems in protein crystal-
lization studies and many proof-of-principle studies.
The goal of this study was not to determine the structures
of these proteins, but to evaluate the feasibility of SMX
experiments by using the current capabilities of the GM/CA
23-ID-D beamline in combination with various delivery
methods. For this, microrystals in a size range from 5 to 20 mm
were grown and delivered to the X-ray beam using a high-
viscosity injector (Weierstall et al., 2014). We also tested two
viscous media as crystal carriers: lipidic cubic phase (LCP)
and poly(ethylene oxide) (PEO), a gel polymer with a high
molecular weight (8 000 000). Additionally, we developed a
new program at APS for real-time data monitoring and
reduction, as well as a new version of the Cheetah software
(Cheetah-cbf) for data reduction (hit-finding) that reads raw
images from the PILATUS detector. In this proof-of-principle
study, we determined the feasibility of structure determination
of several proteins, including A2AAR, PC, Flpp3, proteinase K
and lysozyme, using SMX. Much faster data collection will be
possible using the upgraded high-brightness synchrotron
sources and faster detectors that are under way or planned at
many facilities.
2. Materials and methods
2.1. Microcrystal sample preparation
A total of six proteins were screened in this study: the
human A2A adenosine receptor containing the BRIL fusion
protein in the third intracellular loop (A2AAR); PC from
Thermosynechococcus elongatus; Flpp3 from F. tularensis;
chicken egg-white lysozyme; thaumatin from Thaumatococcus
daniellii; and proteinase K from Tritirachium album.
Protein production and crystal sample preparations of all
proteins screened were as follows. Expression, purification
and crystallization of human A2AAR were performed as
described previously (Batyuk et al., 2016; Liu et al., 2012).
Briefly, concentrated protein (25 mg ml1) was reconstituted
in LCP by mixing with molten monoolein/cholesterol
[9:1(w/w)] using a syringe mixer (Cheng et al., 1998). Crystals
of approximately 5 mm were obtained in Hamilton syringes by
injecting 6 ml of protein–LCP mixture into a 100 ml syringe
filled with 60 ml of a precipitant solution consisting of 0.1M
sodium citrate pH 5.0, 32% PEG 400, 0.075M sodium thio-
cyanate. Flpp3 was purified as described previously (Zook et
al., 2015). 10–15 mm crystals of Flpp3 were grown by incu-
bating the protein at 20 mg ml1 in a low ionic strength buffer
(0.05M NaCl, 0.02M Tris pH 6.4) containing 1 U ml1 factor
Xa protease to cleave the His tag. Chicken egg-white lysozyme
(catalog no. 62970, Sigma) crystals of sizes between 5 and
10 mm were grown using the batch and vapor-diffusion
methods. For the batch method, 40 ml of lysozyme at
50 mg ml1 in 0.02M sodium acetate pH 4.6 was mixed with
200 ml of a precipitant solution consisting of 18%(w/v) NaCl,
6%(w/v) PEG 6000, 0.1M sodium acetate pH 3.0. Lysozyme
microcrystals formed immediately at room temperature and
were centrifuged at 500g for 5 min. For the vapor-diffusion
method, lysozyme was crystallized from a kit purchased from
Hampton Research (catalog no. HR7-108). A protein stock
solution was made at a concentration of 100 mg ml1 in
deionized water. Hanging drops consisted of equal volumes of
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either 80 or 100 mg ml1 protein solution and reservoir solu-
tion consisting of 30%(w/v) PEG 5000 monomethyl ether,
1.0M sodium chloride, 0.05M sodium acetate trihydrate pH
4.6. Thaumatin was purchased from Sigma (catalog No. T7638)
to grow microcrystals of 20 mm in size using the vapor-
diffusion method at room temperature by mixing equal
volumes of a protein solution at 40 mg ml1 and a precipitant
solution consisting of 0.1M sodium citrate pH 5.6, 0.75M
potassium/sodium tartrate. Proteinase K (catalog No. P2308,
Sigma) was crystallized using the batch method by mixing
equal volumes of a protein solution at 40 mg ml1 in 0.02M
MES pH 6.5 and a precipitant solution composed of 0.1M
MES pH 6.5, 0.5M sodium nitrate, 0.1M calcium chloride.
Crystals between 10 and 15 mm in size appeared after 20 min
incubation at 20C. PC was isolated from T. elongatus cells and
purified as described previously (Fromme et al., 2015). PC
crystals (20 mm) were produced at 4C using the batch
method at a starting protein concentration of 20 mg ml1 and
using 0.075M HEPES pH 7.0, 0.02M MgCl2, 9%(w/v) PEG
3350 as precipitant. Crystals were grown at 4C, appeared
within 12 h and were pooled together before mixing with the
viscous media. Except for A2AAR, all crystallization setups
were carried out onsite at the experimental laboratory of
GM/CA beamline 23-ID-D.
2.2. Mixing crystals with the injection carrier media
A2AAR crystals were grown in LCP and injected directly
into the X-ray beam (LCP-embedded microcrystals of A2AAR
are shown in Supplementary Fig. S1). For the other proteins,
two viscous media were used as carriers to deliver the crystals
into the X-ray beam path. LCP was used to embed previously
grown crystals of lysozyme (Supplementary Fig. S1), thau-
matin and Flpp3. Crystal suspensions of approximately 20 ml
were pooled together and centrifuged at 500g for 5 min. The
supernatant was removed and the remaining microcrystal
suspension was mixed with molten monoolein lipid in a
lipid:protein ratio of 3:2(v:v) using a dual-syringe lipid mixer
until a homogeneous and transparent LCP was formed
(Caffrey & Cherezov, 2009; Cheng et al., 1998). PEO was used
for the first time as a carrier to
suspend previously formed crys-
tals of Flpp3, PC and proteinase
K. Fig. 1 shows the setup
with which the crystals were
embedded into the PEO medium.
Prior to mixing with PEO, all
crystal suspensions were centri-
fuged at 500g for 5 min at 20C. A
13%(w/v) PEO gel was prepared
by inserting 6.5 mg PEO powder
(Sigma–Aldrich) into the back
end of a 250 ml syringe with a
ferrule in place and with Parafilm
covering the removable needle
end. Subsequently, 50 ml of the
corresponding precipitant solu-
tion was pipetted into the back
end of the syringe, the plunger
was inserted and the syringe was
flipped upside down and moved
up and down to remove air and to
dissolve the PEO. To achieve a
homogeneous PEO suspension, a
100 ml syringe was connected to
the 250 ml syringe using a syringe
coupler (Cheng et al., 1998) and
the plungers of both syringes
were then pushed back and forth
until a fully clear suspension was
achieved. In another 100 ml
syringe, the desired volume of
crystals was drawn from the
crystal pellet. Finally, a 4:1 volu-
metric ratio of PEO gel and
concentrated crystals were mixed
by pushing the crystals and gel
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Figure 1
Diagram depicting the procedure used to prepare the poly(ethylene oxide) (PEO) gel and embed the
crystals within it. (a) 0.6 mg of PEO is weighed into the back end of a 250 ml syringe and the PEO powder is
then evenly distributed throughout the syringe by tapping the syringe while the syringe is horizontal (not
shown). (b) The crystal precipitant (50 ml) is then added via a pipette to the back end of the syringe and the
plunger is inserted. (c) The 250 ml syringe containing the precipitant solution and PEO is then connected to
a 100 ml syringe via a syringe coupler (Cheng et al., 1998) and the PEO is mixed until the suspension
becomes clear by pushing the plungers of each syringe back and forth. The desired amount of PEO gel is
then pushed into the 100 ml syringe and the syringe coupler is disconnected. (d) A second 100 ml syringe
containing a concentrated slurry of crystals is connected to the 100 ml syringe containing the PEO gel and
the crystals are then embedded into the gel by pushing the plungers back and forth until the mixture is
homogenous.
through a syringe coupler (Cheng et al., 1998) back and forth
until homogeneity was achieved. Supplementary Fig. S2 shows
PC and proteinase K crystals after being mixed with the PEO
gel.
In all cases the crystal concentration was adjusted so that
mainly single-crystal hits were observed. The crystal mixtures
were loaded directly from the Hamilton syringe into the LCP
injector sample reservoir.
2.3. Serial data collection on the GM/CA 23-ID-D beamline
Serial data collection was performed on the GM/CA
23-ID-D beamline at the APS. The GM/CA beamline is
equipped with a quad-minibeam collimator that provides
high-intensity beams between 5 and 20 mm in diameter with a
scatter-guard aperture (Fischetti et al., 2009; Sanishvili et al.,
2008); the JBluIce–EPICS GUI software allows users to fully
exploit the rapid beam-size change and various models of data
collection (Hilgart et al., 2011; Pothineni et al., 2014; Stepanov
et al., 2011). A new optical layout has been designed and will
be installed shortly to produce intense microfocused beams as
small as 1 mm (Fischetti et al., 2013).
Microcrystal/carrier suspensions were injected to the
intersection with the X-ray beam using the viscous LCP
injector (Weierstall et al., 2014) with a 50 mm inner diameter
fused silica capillary (‘nozzle’). This type of nozzle was chosen
according to the crystal size to avoid shearing and breakage of
the crystals during injection and to avoid nozzle clogging, as
well as to minimize the background scattering from crystal
carrier streams. For all our experiments a 20 ml reservoir was
used. The injector was mounted on translation stages to align
the jet perpendicular to the X-ray beam path (Fig. 2). The
crystal carrier stream was extruded out of the nozzle by a
pressure that varied between 0.2 and 1 MPa depending on the
flow rate of the sample, which was also varied depending on
the sample composition and the observed diffraction. A
nitrogen-gas sheath was introduced at the point of extrusion to
prevent curling of the viscous medium stream. An in-line high-
resolution microscope was used to align
the nozzle to the beam and to observe
the stream. A sample catcher consisting
of a small diameter hyperdermic tube
was placed opposite to the jet to catch
the extruded waste sample. The catcher
was connected to a vacuum pump via
Tygon tubing with an inline particulate
trap to protect the pump. The small tube
tended to clog and was replaced by a 14
00
tube. A schematic of the experimental
setup used at the GM/CA 23-ID-D
beamline is shown in Fig. 2.
During our two experiments, the
beam generated by the undulator was
monochromated to 0.02% bandwidth
using a Si(111) monochromator and
focused using Kirkpatrick–Baez (K-B)
mirrors. The beamline operated at an
energy of 12 keV (wavelength 1.03 A˚)
and the flux at the focus using a 10 mm
(FWHM) beam size was 3.0–4.1 
1011 photons s1. Tens to hundreds of
thousands of single-shot diffraction
patterns of randomly oriented micro-
crystals were recorded on a PILATUS3
6M detector running in a continuous
shutterless mode at a readout rate of
10 Hz (100 ms exposure time) while
crystals were passing through the beam.
The sample-to-detector distance varied
between 300 and 550 mm depending on
the sample diffraction quality. Although
the crystal flow rate was varied based
on the observed diffraction, most
measurements were performed at an
average flow rate which varied from 17
to 182 nl min1 depending on the
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Figure 2
Experimental setup at the GM/CA 23-ID-D beamline. (a) Schematic diagram of the setup. (b) LCP
injector (Weierstall et al., 2014) mounted on translation stages (not shown). The catcher is also
shown. (c) View of the LCP stream extruding out of a 50 mm glass capillary nozzle. The intersection
point of the two white dashed lines indicates the position of the X-ray beam.
crystal density, corresponding to an average jet velocity of
between 120 and 1250 mm s1 in the 50 mm diameter nozzle.
Thus, we estimated that the exposure time of a single micro-
crystal across the 10 mm X-ray beam was between 8 ms (for a
flow rate of 182 nl min1) and 85 ms (for a flow rate of
17 nl min1).
2.4. Data processing, model building and refinement
Data analysis is one of the major challenges of the serial
crystallography approach owing to the serial nature of data
collection from randomly oriented crystals of varying size and
quality, the snapshot diffraction patterns of which consist of
reflections measured with unknown partiality. In addition, the
data collected during an experiment consist of actual crystal
diffraction patterns and empty patterns (no crystals in the
beam), resulting in the generation of terabytes of data. In
order to monitor the hit rate and quality of large amounts of
data in real time, we developed a real-time Python-based hit
finder at APS. This program uses multiple processors to
perform background subtraction and basic spot finding on
each image as soon as it is transferred from the detector. Data
reduction was also performed offsite using a modified version
of Cheetah (Barty et al., 2014), called Cheetah-cbf, designed to
read raw cbf images from the PILATUS detector and identify
crystal diffraction patterns (hits) in HDF5 format, the suitable
format for data processing with CrystFEL. Cheetah-cbf was
installed on the GM/CA 23-ID-D beamline; it is accessible to
all APS users and can also be used offsite. For each sample the
peak-finding thresholds were carefully tailored to maximize
the number of crystal hits and the number of Bragg peaks in
each diffraction pattern.
Sorted diffraction patterns identified during the hit-finding
process were subjected to indexing and structure-factor
integration using CrystFEL v.0.6.2 (White et al., 2012, 2013,
2016). CrystFEL contains widely used algorithms such as
MOSFLM (Powell et al., 2013), DirAx (Duisenberg, 1992) and
XDS (Kabsch, 2010), and a new algorithm known as asdf,
which was recently implemented in CrystFEL. The new
indexing option called ‘retry’, which was recently imple-
mented in CrystFEL (White et al., 2016), allowed a significant
increase in the number of successfully indexed patterns. This
new option rejects a small fraction of the weakest spots and
retries indexing. After each pattern was indexed, the inten-
sities were merged and integrated using a Monte Carlo algo-
rithm (Kirian et al., 2010, Kirian et al., 2011). Data-collection
statistics for all of the proteins tested in this study are
summarized in Table 1. The resolution-cutoff criteria were
based on signal-to-noise ratios, completeness and correlation
coefficients. The maximum radiation dose per crystal was
estimated using the RADDOSE-3D server (Zeldin, Broc-
khauser et al., 2013; Zeldin, Gerstel et al., 2013), assuming
cuboid crystals for all four crystal dimensions tested in this
study (5  5  5, 10  10  10, 15  15  15 and 20  20 
20 mm), a 10 mm beamsize, a photon flux of 3.0–4.1 
1011 photons s1, an energy of 12 keV and exposure times of
6.5 and 85 ms, as described above. The results of this analysis
are summarized in Table 1.
After integration with CrystFEL, the initial phases were
obtained by molecular replacement with MOLREP (Vagin &
Teplyakov, 2010) using known structures of the proteins from
the PDB [the PDB entries used were 5k2c for A2AAR (Batyuk
et al., 2016), 4ziz for PC (Fromme et al., 2015), 4zix for lyso-
zyme (Fromme et al., 2015), 5avj for proteinase K (Yazawa et
al., 2016) and 2mu4 for Flpp3 (Zook et al., 2015)]. Additional
remodeling performed by the MR_protocol algorithm in
Rosetta (Terwilliger et al., 2012) was required to obtain a
sufficient phasing solution for Flpp3: loops from the published
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Table 1
SMX data-collection statistics.
Values in parentheses are for the highest resolution shell.
A2AAR Lysozyme Phycocyanin Flpp3 Proteinase K
Viscous medium LCP LCP PEO LCP/PEO PEO
Crystal size (mm) 5 5–10 20 20 10–15
Sample-to-detector distance (mm) 550 300 300 300 400
Average flow rate (nl min1) 56 17 182 155 79
Average crystal velocity (mm s1) 570 120 1550 1315 675
Average exposure time/crystal (ms) 18.0 85.0 6.5 7.6 15.0
Maximum dose per crystal (MGy) 0.1 0.1 0.1 0.1 0.1
Data-collection time (h) 14 12 5 2.5 3
Protein/carrier volume (ml) 52.3 26.0 60 27.5 13.0
Wavelength (A˚) 1.03 1.03 1.03 1.03 1.03
Maximum resolution observed (A˚) 3.1 2.0 2.5 1.6 2.2
Resolution (A˚) 45–3.20 (3.28–3.20) 35–2.05 (2.10–2.05) 50–3.10 (3.18–3.10) 36.8–3.00 (3.08–3.00) 50–2.65 (2.72–2.65)
Space group C2221 P43212 H32 P21 P43212
a, b, c (A˚) 39.4, 179.5, 140.3 79.1, 79.1, 38.0 186.4, 186.4, 60.3 30.3, 52.3, 36.9 68.3, 68.3, 108.2
, ,  () 90, 90, 90 90, 90, 90 90, 90, 120 90, 92, 90 90, 90, 90
No. of collected images 503006 364724 159809 115672 97772
No. of hits/indexed patterns 14711/5287 124800/18648 7912/1826 13383/3157 4497/817
hI/(I)i 7.7 (0.3) 11.2 (0.4) 7.6 (1.9) 5.1 (2.5) 4.6 (0.3)
Multiplicity 142.6 (33.2) 873.3 (43.9) 156.4 (4.8) 45.1 (13.0) 104.8 (40.6)
Completeness (%) 99.8 99.8 99.7 100 99.2
CC* (%) 0.992 (0.423) 0.978 (0.436) 0.986 (0.799) 0.973 (0.856) 0.954 (0.431)
Rsplit (%) 13.4 (506.0) 10.7 (242.8) 14.2 (73.09) 25.9 (38.8) 22.4 (331.0)
NMR structure (PDB entry 2mu4) were removed and then
remodeled, with a total of 1000 new models, using fragments
generated from the Rosetta webserver and initial phases
provided by Phaser (McCoy et al., 2007). The ten lowest
energy models were then resubmitted to Phaser, with several
sufficient solutions obtained. The best model had an LLG
score of 56.8 and a TFZ of 7.2. A model was built using the
AutoBuilder protocol in PHENIX (Terwilliger et al., 2008),
and the model was rephased for a final solution with an LLG
of 300.7 and a TFZ of 14.7. Water molecules and ligands were
removed from the reference structures for the phasing step.
Structure refinement was carried out through multiple itera-
tions of REFMAC5 (Murshudov et al., 2011) to refine atomic
coordinates and isotropic B factors. Manual inspection of the
structures was carried out using Coot (Emsley & Cowtan,
2004) after each refinement step. The figures were prepared
with PyMOL (Schro¨dinger). Data-refinement statistics for all
structures solved in this study are summarized in Table 2.
Electron-density maps were calculated with theMAPS tool in
the PHENIX software suite (Adams et al., 2010). Validation of
all structures was carried out with the validation tools in the
PHENIX software suite (Adams et al., 2010).
3. Results and discussions
Here, we demonstrate that the LCP injector-based SMX
method is feasible at the GM/CA 23-ID-D beamline and can
be used to determine the structures of a range of proteins of
different sizes and types from crystal sizes between 5 and
20 mm. In addition, we introduce PEO gel as a novel carrier
medium to deliver microcrystals into the X-ray beam, which
can be utilized in serial crystallography experiments at
synchrotron sources and XFELs. For our study, we used the
high-viscosity injector developed at Arizona State University
(Weierstall et al., 2014) to deliver microcrystals into the 10 mm
X-ray beam path. Diffraction data were collected in a
continuous shutterless mode using a PILATUS3 6M detector
operating at 10 Hz. The experimental setup at the beamline is
shown in Fig. 2. To validate the proof-of-principle of the SMX
approach, we chose a set of six proteins that includes one
membrane protein, four soluble proteins and one multiprotein
cofactor complex of different sizes as model systems: A2AAR,
Flpp3, proteinase K, lysozyme, thaumatin and PC. Data from
thaumatin microcrystals embedded in LCP were collected
with a hit rate of 6%. However, the number of indexed
patterns was insufficient to yield a complete data set for this
protein. Complete data sets were obtained from microcrystals
of two proteins embedded in LCP (A2AAR and lysozyme) and
three proteins in PEO gel (PC, Flpp3 and proteinase K), which
are described in further detail below.
3.1. Protein structures in LCP viscous medium
3.1.1. Lysozyme. Lysozyme was chosen as a test protein to
evaluate the SMX method. Lysozyme was first crystallized and
pelleted and was then reconstituted into LCP as described
previously (Fromme et al., 2015; Liu et al., 2014). The resulting
microcrystal–LCP suspension, containing lysozyme crystals of
between 5 and 10 mm in size, was then transferred to the LCP
injector and diffraction data were collected using an LCP flow
rate of 17 nl min1. Lysozyme crystals were crystallized in
space group P43212 and were occasionally seen to diffract to
beyond 2.0 A˚ resolution (Supplementary Fig. S3). A total of
364 724 images were collected, of which 124 800 were classi-
fied as hits (hit rate 34.2%) and 18 648 were successfully
indexed. The final data-collection statistics are given in
Table 1. The structure of lysozyme was solved by molecular
replacement with PDB entry 4zix (Fromme et al., 2015) as a
search model without waters or ions. The structure was refined
at a resolution of 2.05 A˚ with an Rwork and Rfree of 22.8 and
26.8%, respectively (Table 1). The final refinement statistics
are given in Table 2. The resulting experimental maps were of
excellent quality, revealing the presence of 18 water molecules,
three chloride ions and a sodium ion. The sodium ion shows an
octahedral coordination by four neighboring residues and two
water molecules (Fig. 3).
To ensure the validity of our procedure, the structure
determined in our study was compared with those obtained by
the serial method at XFELs using an LCP injector (Fromme et
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Table 2
SMX data-refinement statistics.
A2AAR Lysozyme Phycocyanin Proteinase K
Total reflections 25266 29412 17002 29685
No. of reflections used in refinement 7702 7164 6280 5294
Rwork/Rfree (%) 24.8/28.6 22.8/26.8 17.2/20.5 22.5/24.3
No. of atoms 3140 1023 2626 2041
Protein 2989 1002 2499 2032
Water and others (ligands or ions) 151 21 127 9
Average B value (A˚2) 109.2 34.9 48.2 61.3
R.m.s. deviations from ideal values
Bonds (A˚) 0.009 0.013 0.011 0.008
Angles () 1.614 1.306 2.093 1.126
Ramachandran plot statistics (%)
Favored 98.9 97.6 98.8 97.1
Allowed 1.1 2.4 1.2 2.5
Disallowed 0 0 0 0.4
Rotamer outliers 0 1 2 0
PDB code 5uvi 5uvj 5uvk 5uvl
al., 2015) and a GDVN injector (Boutet et al., 2012), and at
synchrotron sources using a high-viscosity injector (Botha et
al., 2015), glass capillaries (Stellato et al., 2014) and cryocooled
crystals on a fixed target (Murray et al., 2015). All structures
superimposed very well, with root-mean-square deviation
(r.m.s.d.) values of 0.4 A˚ for C atoms (0.8 A˚ for all atoms
of the protein). Only small differences were detected at the
side chains of highly solvent-exposed residues, which can be
explained in terms of the variation in crystal-preparation
protocols and crystal-delivery methods. Analysis of the B-
factor distribution revealed no significant differences overall
between our structure (35 A˚2) and the cryocooled structure
(31 A˚2; Murray et al., 2015) and those collected at XFELs
using the GDVN injector (35 A˚2; Boutet et al., 2012) and the
LCP injector (27 A˚2; Fromme et al., 2015). In addition, lower B
factors are observed for our structure compared with those
determined using glass capillaries (52 A˚2; Stellato et al., 2014)
and the high-viscosity injector of Botha and coworkers (48 A˚2;
Botha et al., 2015) .
It has been suggested that at room temperature the
radiation-dose limit above which radiation damage becomes
significant is 0.3 MGy (Nave & Garman, 2005). In a recent
study carried out by Coquelle and coworkers in which a room-
temperature raster-scanning serial crystallography method
was used at the ESRF synchrotron, the maximum dose per
crystal was estimated to be between 3.2 and 29.1 MGy
(Coquelle et al., 2015). They demonstrated that mainly the S
atoms in lysozyme and, in particular, disulfide bonds were
damaged by radiation to some extent, although other struc-
tural information was not compromised (Coquelle et al., 2015).
In our study the average maximum radiation dose per crystal
was estimated to be 0.1 MGy (Table 1), which is below the
dose beyond which radiation damage is expected. In order to
assess whether the disulfide bonds of our lysozyme structure
were radiation-damaged considering the above radiation dose,
we calculated the structure-factor amplitude Fourier differ-
ence (Fo  Fo) maps between our data set and the data set
collected using the LCP injector at the LCLS (Fromme et al.,
2015). The maximum radiation dose per crystal for the SFX
data was 2.5 MGy, which is much higher than the maximum
dose limit of 0.3 MGy (Nave & Garman, 2005). As shown in
Fig. 4, none of the four disulfide bonds in lysozyme, including
the disulfide bridge Cys64–Cys80, which was considered to be
the most radiation-sensitive at room temperature by Coquelle
and coworkers, show negative peaks at the S atoms or at the
disulfide bridges. In addition, radiation damage was not visible
in the 2mFo  Fo and mFo  Fo maps (Fig. 4), indicating that
the disulfide bonds were not broken and the structural infor-
mation has not been compromised.
3.1.2. A2AAR. Microcrystals of A2AAR were injected into
the X-ray beam path at an average flow rate of 56 nl min1
and measured for 14 h. Less than 55 ml of LCP–sample was
necessary to collect a total of 500 003 images, of which 14 711
were identified as hits (3% hit rate) and 5287 (indexing yield
36%) were successfully indexed in space group C2221
(Table 1). Fig. 5 shows a diffraction pattern of a single A2AAR
microcrystal. The structure of A2AAR was solved by
molecular replacement using the recently reported high-
resolution SFX structure (PDB entry 5k2c; Batyuk et al., 2016)
without waters and ligands. The final structure was refined to
3.2 A˚ resolution with an Rwork and Rfree of 24.2 and 28.6%,
respectively (Table 1). The final data-collection and refine-
ment statistics are given in Tables 1 and 2. Despite the medium
resolution of the structure, the high quality of the electron-
density maps allowed us to model the ligand ZM241385, three
cholesterol molecules and three other lipids (Fig. 6). However,
the clusters of water molecules previously described in the
structures determined by SFX and under cryoconditions,
which were demonstrated to play a key role in maintaining the
stability of the receptor and in ligand binding, were not
identified in our medium-resolution A2AAR structure. Also,
the sodium ion which has been described to play a key role in
the receptor-activation mechanism (Katritch et al., 2014) was
not identified in our structure, possibly for the same reason.
We compared the structure of A2AAR obtained in our study
with high-resolution structures obtained by SFX (Batyuk et
al., 2016) and from cryocooled crystals (Liu et al., 2012). All
structures aligned very closely, with r.m.s.d. values for C
atoms of 0.3 and 0.4 A˚ for the SFX and synchrotron structures,
respectively. Larger differences were found around the side
chains of solvent-exposed bulky residues, the orientation of
which could not be well modeled. The discrepancies were
slightly larger in the BRIL fusion protein, where small
differences were even observed along the backbone of this
protein. The average B factors were also significantly higher
(109 A˚2 for the whole protein, 148 A˚2 for the BRIL fragment
and 96 A˚2 for the A2AAR fragment) compared with that of the
room-temperature structure solved by SFX (40 A˚2 for the
whole protein; Batyuk et al., 2016). Also, the observed high B
factors may explain why no water molecules are seen in our
structure. High average B factors (90–100 A˚2) have so far been
reported in the literature for 86 structures deposited in the
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Figure 3
Quality of the electron-density maps displayed around the octahedral
coordination of sodium in the lysozyme structure. 2mFo  DFc electron-
density maps are shown as light pink mesh contoured at 1. The residues
coordinating the Na atom (Ser60, Cys64, Arg71 and Ser72) are shown as a
magenta stick representation. Waters W3 and W4 are shown as red
spheres. The interactions between sodium and its ligands are represented
as blue dotted lines.
PDB at resolutions between 3.15 and 3.25 A˚. In fact, high B
factors should be expected when solving medium- to low-
resolution crystallographic structures at room temperature.
The A2AAR protein has 15 Cys residues in its sequence,
eight of which form four disulfide bonds (Cys71–Cys159,
Cys74–Cys146, Cys77–Cys166 and Cys259–Cys262), which
might be subject to radiation damage. In order to assess the
effect of radiation damage, we calculated the structure-factor
amplitude Fourier difference (Fo  Fo) maps between our
data set and the undamaged data set collected at the LCLS
(Batyuk et al., 2016). As shown in Supplementary Fig. S4, the
absence of negative electron-density peaks around disulfide
bonds indicates that the radiation-damage effect is limited, as
expected by the estimated radiation dose of 0.2 MGy. The
2mFo  Fo and mFo  Fo electron-density maps also
demonstrate that the disulfide bonds are not broken
(Supplementary Fig. S4).
3.2. Protein structures in the novel PEO viscous medium
3.2.1. Flpp3. A highly concentrated microcrystal pellet was
mixed with either LCP or PEO gel. The LCP- and PEO-
embedded microcrystals were trans-
ferred to the high-viscosity injector
(Weierstall et al., 2014) and presented
into the beam in a free-flowing stream.
Diffraction data for the Flpp3 micro-
crystals were collected at an average
flow rate of 155 nl min1, consuming
less than 30 ml of protein/carrier sample,
which yielded 13 383 hits, of which 3157
were indexed at 3.0 A˚ resolution (Table
1). The final data set was generated
from reflections collected from both
PEO and LCP samples. Efforts to
generate a sufficient model for Flpp3 at
3.0 A˚ resolution are ongoing. The final
data-collection and refinement statistics
for the Flpp3 data set are shown in
Tables 1 and 2.
3.2.2. Phycocyanin (PC). The PEO
with embedded PC microcrystal
(20 mm) suspension was injected at an
average flow rate of 182 nl min1 and
159 809 images were collected, which
correspond to an effective measurement
time of5 h (Table 1). This resulted in a
PC sample consumption of about 60 ml.
The structure of PC was determined to
3.1 A˚ resolution from 1826 indexed
patterns (indexing rate 23%; Table 1).
The final data-collection and refinement
statistics of the PC data set are shown in
Tables 1 and 2. Supplementary Fig. S5
shows a diffraction pattern of a single
PC–PEO microcrystal. Slightly smeared
Bragg peaks were observed, which
indicates that the PC crystals were
rotating azimuthally around the X-ray
beam axis during the 100 ms exposure.
This has previously been observed for
lysozyme microcrystals embedded in
LCP with 100 ms exposures (Botha et
al., 2015). The structure of PC was
solved by molecular replacement using
the previously solved LCP-injected SFX
structure as a search model, with water
molecules and chromophores removed
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Figure 4
Electron-density maps displayed around the four disulfide bridges in lysozyme: (a) Cys6–Cys127,
(b) Cys30–Cys115, (c) Cys64–Cys80 and (d) Cys76–Cys94. Cysteines and neighboring residues are
represented as pink sticks. Left panels, structure-factor amplitude Fourier difference (Fo Fo) maps
at 3 between our data and the data set collected at LCLS (Fromme et al., 2015), with red and green
contours indicating negative and positive density, respectively. Right panels, 2mFoDFc (light pink
mesh, contoured at 1) and mFo  DFc (red and green meshes, contoured at 3) maps.
(PDB entry 4ziz; Fromme et al.,
2015). The PC structure was
refined to 3.1 A˚ resolution, with
final Rwork and Rfree values of 17.2
and 20.4%, respectively. The
quality of the structure can be
assessed from the 2mFo  DFc
electron-density maps of the three
chromophores of PC (Fig. 7a). To
further evaluate the quality of our
structure, we compared our
model with the two SFX struc-
tures recently described using the
LCP injector (PDB entry 4ziz;
Fromme et al., 2015) and the
GDVN injector (PDB entry 4q70;
R. Fromme, S. Roy-Chowdhury, S.
Basu, C. Yoon, D. Brune & P.
Fromme, unpublished work). The
three structures aligned very
closely with each other, with
r.m.s.d. values for C atoms of 0.1
and 0.7 A˚ for the LCP and GDVN
structures, respectively. Further-
more, we compared the PC
structure with the structure
previously solved at a synchro-
tron using a single cryocooled
crystal (PDB entry 3l0f; R.
Fromme, D. Brune & P. Fromme,
unpublished work). Both struc-
tures superimposed very well,
with an r.m.s.d. value of 0.2 A˚ for
all C atoms. An r.m.s.d. value of
0.5 A˚ for all atoms indicates that
small differences were, however,
observed in the loop regions and
in the solvent-exposed regions.
The average B factors for both
chains of PC (45 A˚2 for chain A
and 51 A˚2 for chain B) showed no
significant differences from the
LCP structure (38 A˚2 for chain A
and 45 A˚2 for chain B). However,
higher average B factors were
observed compared with those of
the cryocooled (21 A˚2 for chain A
and 25 A˚2 for chain B) and the
GDVN (26 A˚2 for chain A and
32 A˚2 for chain B) structures.
These differences are attribu-
table, to a greater extent, to
the higher resolution of the
structures collected at cryogenic
temperatures (1.35 A˚2; R.
Fromme, D. Brune & P. Fromme,
unpublished work) and using a
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Figure 5
Diffraction pattern of a single microcrystal of A2AAR in LCP. (a) Raw diffraction pattern with resolution
rings at 3 A˚ and 4 A˚ showing visible Bragg spots extending to about 3.5 A˚ resolution (red inset panel). The
green inset panel shows low-resolution Bragg spots. (b) The same diffraction pattern as in (a) after indexing
with resolution rings. (c) Closer view of the red boxed area highlighted in (b).
Figure 6
The quality of the 2mFoDFc electron-density maps reflects the good quality of the collected data. (a) The
A2AAR protein is shown as a green cartoon and the BRIL fusion protein is shown as a pink cartoon. The
ligand ZM241385 (magenta), three cholesterols (orange) and three lipids (yellow and cyan) are shown as
stick representations. (b) 2mFo  DFc electron-density maps around the residues, shown as sticks, for
helices I, II and II.
liquid jet (1.9 A˚2; R. Fromme, S. Roy-Chowdhury, S. Basu, C.
Yoon, D. Brune & P. Fromme, unpublished work).
3.2.3. Proteinase K. Diffraction data for proteinase K (PK)
microcrystals embedded in PEO gel were collected at a
constant flow rate of 79 nl min1 with an effective measure-
ment time of 3 h, during which nearly 100 000 images were
recorded. This resulted in a PK sample consumption of less
than 15 ml. A total of 4497 images with diffraction to a
maximum resolution of 2.2 A˚ were identified as hits (hit rate
4.2%), of which 817 were successfully indexed in space group
P43212 (Table 1). The final data-collection and refinement
statistics are given in Tables 1 and 2. Supplementary Fig. S6
shows a diffraction pattern from a single proteinase K–PEO
microcrystal. As with PC, slightly smeared Bragg peaks were
also observed, which indicates that the proteinase K crystals
were rotating during the 100 ms exposure. Phasing was
performed by molecular replacement using the cryocooled
structure at a synchrotron (PDB entry 5avj; Yazawa et al.,
2016) as a search model. The final refinement gave an Rwork
and Rfree of 22.5 and 24.3%, respectively. The proteinase K
structure was determined to 2.65 A˚ resolution and, overall,
our structure is very similar to that solved using cryocooled
crystals, with an r.m.s.d. value of less than 0.1 A˚ for all C
atoms. The average B factor was 61 A˚2, as expected for a
structure solved to 2.65 A˚ resolution at room temperature. In
our structure, no water molecules were identified; however,
the two Ca atoms that contribute to protein stability were
clearly visible. The 2mFo  DFc electron-density maps around
the one of these two Ca atoms can be used to assess the high
quality of our proteinase K structure (Fig. 7b).
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Figure 7
2mFo  DFc electron-density maps of PC (a) and proteinase K (b) contoured at 1. (a) The two PC subunits (, blue; , pink) are shown in cartoon
representation. The three chromophores are shown as yellow sticks. A closer view of the chromophore in the black box is shown in the right panel. (b)
Proteinase K is shown in a yellow cartoon and stick representation. One of the two Ca atoms is shown as a green sphere. A closer view of the Ca atom is
illustrated in the right panel.
3.3. PEO gel: a novel high-viscosity medium as a crystal
carrier for serial crystallography
One of the greatest limitations of SMX experiments at
synchrotron sources using monochromatic X-rays is that the
crystals have to be exposed for longer times, which decreases
the data-acquisition rates at these facilities (typically <20 Hz)
compared with those at XFELs (120 Hz at LCLS and 60 Hz at
SACLA). Delivering crystals in a liquid jet using the GDVN
injector has been successfully used for many SFX experiments
at XFELs (for a review, see Martin-Garcia et al., 2016). The
GDVN injector operates at a minimal flow rate of 10 ml min1,
which is too fast even for the repetition rates of current
XFELs; thus, most of the sample is wasted and large sample
volumes are needed to obtain a complete data set. Sample
waste is even much more noticeable at the low repetition rates
at synchrotrons, which makes liquid injectors impractical.
Additionally, with the high flow rate of the GDVN the crystal
transit of the X-ray beam is submillisecond, resulting in very
weak diffraction; therefore, the GDVN is not recommended
for SMX experiments. New strategies have allowed crystals to
be delivered into the X-ray beam path more efficiently so that
sample waste is markedly reduced. One of these methods is
the use of a high-viscosity medium extruded as a continuous
stream using the LCP injector (Weierstall et al., 2014) at very
slow flow rates (typically 1–300 nl min1), allowing extremely
low sample consumption (less than 1 mg) compared with a
GDVN injector (10–100 mg protein).
In our study, we have used LCP as a crystal carrier medium
which can also be used as a host matrix to crystallize
membrane proteins (Caffrey & Cherezov, 2009). To date, the
use of LCP has led to the structure determination of a wide
range of membrane proteins, including ion channels, trans-
porters, enzymes, -barrels and, in particular, GPCRs (Xiang
et al., 2016). More recently, LCP has been successfully used to
deliver previously grown soluble protein crystals into the
X-ray beam in serial crystallography experiments, allowing
their structure determination using XFELs (Fromme et al.,
2015) and synchrotrons (Botha et al., 2015; Nogly et al., 2015;
Stellato et al., 2014). In the case of membrane proteins, crystals
have to be grown in LCP since mixing membrane-protein
crystals pregrown in solution in the form of protein–detergent
micelles with LCP typically leads to dissolution of the crystals.
This is probably owing to partitioning of detergent molecules
into the lipid bilayer of LCP, leading to crystal dissolution and
protein denaturation.
A novel high-viscosity medium has now been presented
here to deliver protein microcrystals for SMX experiments. A
gel polymer of high-molecular-weight poly(ethylene oxide)
(PEO) has been used as a host matrix to embed previously
grown protein microcrystals of Flpp3, proteinase K and PC.
PEO has the same chemical composition as PEG, a commonly
used precipitating agent in protein crystallography, but owing
to its high molecular weight it is referred to by a different
name. PEO is one of the most studied water-soluble synthetic
polymers (Bailey, 1976; Hammouda et al., 2004) and is used as
a model for biomedical applications such as in drug-delivery
systems (Dhawan et al., 2005). PEO is soluble in water over a
wide range of degrees of polymerization and at moderate
temperatures (20–30C; Blank, 1974). The use of PEO as a gel
has been reported for the crystallization of a wide variety of
compounds from inorganic solids (Bianconi et al., 1991) to
organic molecules (Chandrasekhar, 2000; Choquesillo-Lazarte
& Garcı´a-Ruiz, 2011) and, recently, proteins (Pietras et al.,
2010). In contrast to Mebiol, a medium that is viscous only at
temperatures above 25C and that has recently been used as a
crystal carrier (Botha et al., 2015), PEO gels are highly stable
at a wide range of temperatures, so that PEO-mediated crystal
delivery can be accomplished at the traditional crystallization
temperatures of 4–30C. Additionally, making PEO gel is a
very simple and straightforward procedure, as described in x2,
leading to a highly homogeneous crystal distribution. PEO
gels, like any other PEG, are compatible with a wide variety of
precipitants commonly used in protein crystallization and
have also been shown to be compatible with a wide variety of
organic solvents that are commonly used as additives in many
crystallization recipes (Choquesillo-Lazarte & Garcı´a-Ruiz,
2011). In all of our experiments, PEO-embedded crystals
established very stable streams and no signs of dehydration
were observed. Fig. 8 shows a comparison of the diffuse
background X-ray scattering of the PEO gel stream compared
with an LCP stream under the same experimental conditions.
Details of the analysis used to evaluate background scattering
is included in the Supporting Information. The characteristic
broad peak at about 4.5 A˚ resolution corresponding to diffuse
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Figure 8
Diffuse background scattering comparison between PEO gel and LCP.
The mean radial intensity over the total number of frames used for each
medium protein is plotted against resolution (1/d). The cyan line
represents the mean radial intensity for lysozyme in LCP medium as a
function of 1/d (or resolution in A˚ on the upper x axis). The green line
represents the mean radial intensity for PC in PEO gel medium as a
function of 1/d. The error or fluctuation in the radial intensity is
quantified using the mean absolute deviation of both media, which is
shown as transparent regions. The lines end at different resolution points
owing to the different crystal-to-detector distances.
scattering of the LCP stream can be seen in Fig. 8. Diffuse
scattering from PEO gel is observed in the 3.3 A˚ resolution
region; it is mostly dominated by water scattering owing to the
low PEO content. Overall, the background scattering from
PEO gel medium is roughly 1.5 times less than that from LCP
in the diffuse-ring regions (resolutions between 3.5 and 6 A˚).
In addition, unlike PEO gel, LCP shows strong scattering at
resolutions of less than 30 A˚, which makes PEO gel an ideal
crystal carrier for protein crystals with large unit cells. A
similar diffuse scattering profile to that of PEO gel has
previously been reported for agarose medium (Conrad et al.,
2015). This is not surprising considering that both PEO and
agarose gels have a high water content (over 90%) compared
with that of LCP (50%). Therefore, agarose and PEO have
been demonstrated to be highly stable viscous media, and are
compatible with a wide variety of crystallization compounds,
making them suitable as crystal carriers.
Preliminary studies indicate that PEO gel is also suitable for
mixing with crystals of membrane proteins such as photo-
system I (PSI), a large membrane-protein complex of
1080 kDa containing 36 protein subunits and more than 300
cofactors. Observation of PSI crystals immersed in PEO by
ultraviolet two-photon excited fluorescence (UV-TPEF),
polarized light and SONICC (Kissick et al., 2011) imaging
indicate that PSI crystals remain intact after mixing with PEO
(Supplementary Fig. S7).
4. Conclusions and outlook
Here, we present a proof-of-concept demonstration for the
data collection of X-ray diffraction data sets suitable for
structure determination from macromolecular, micrometre-
sized crystals at room temperature using a high-viscosity
injector on the GM/CA 23-ID-D beamline at APS. The
number of crystallographic experiments carried out at room
temperature has repaidly grown since the first SFX experi-
ment was conducted at an XFEL in 2009 (Chapman et al.,
2011). XFELs offer unique X-ray beam properties (ultrashort,
extremely intense pulses with a high repetition rate and
coherence), which enables the determination of room-
temperature structures, outrunning most radiation damage.
However, the number of XFEL sources is limited, and
therefore the structural biology community has begun to
adapt the serial crystallography method at conventional
synchrotron sources. Even though synchrotron sources are not
as powerful as XFELs, they can produce sufficiently bright
X-ray beams to enable data to be collected from 5–20 mm-
sized crystals on millisecond timescales. Also, recent and
future developments and upgrades in optics, sample delivery,
detector technology and synchrotrons themselves will make
these radiation sources even more suitable for serial data
collection. Synchrotron sources themselves are more acces-
sible worldwide compared with XFELs. For all of these
reasons, the number of SMX experiments is increasing rapidly
(Botha et al., 2015; Coquelle et al., 2015; Gati et al., 2014;
Hasegawa et al., 2017; Heymann et al., 2014; Huang et al., 2015,
2016; Murray et al., 2015; Nogly et al., 2015; Stellato et al., 2014;
Zander et al., 2015).
The work presented here is an important step towards
adapting the serial approach for room-temperature synchro-
tron data collection from a broad range of protein targets. The
use of high-viscosity crystal carrier media coupled with a fast-
framing detector allowed us not only to synchronize a moving
crystal through an intersecting X-ray beam with the desired
exposure time, but also to considerably reduce sample
consumption by a factor of 20 compared with SFX experi-
ments with the GDVN injector. The utility of a high-viscosity
stream for delivering crystals in the SMX approach has been
demonstrated previously, including the structure determina-
tion of bacteriorhodopsin (bR) at the ESRF (Nogly et al.,
2015) and the structure determination of lysozyme at SLS
(Botha et al., 2015). High-viscosity injectors such as that used
in this study (Weierstall et al., 2014) offer the possibility of
using different viscous materials other than LCP as a crystal
carrier medium. Embedding pregrown crystals in a high-visc-
osity medium may alter the properties of the matrix or even
dissolve the crystals. Thus, the choice of the crystal carrier can
be critical to the success of serial crystallography experiments.
In our study, we have explored LCP medium as a crystal
carrier medium and have shown that PEO gel is also suitable
as a general delivery system for soluble proteins for experi-
ments at synchrotrons as well as XFELs. Based on the visual
techniques mentioned, PEO gels might also be suitable to
deliver membrane-protein crystals in serial crystallography
experiments.
Owing to the low flux density currently achievable at
synchrotron beamlines compared with that of XFELs, we
decided to use crystal sizes that varied from 5 to 20 mm, which
allowed us to collect a complete SMX data set for four
proteins by using no more than 60 ml of protein–carrier
sample. The current implementation of the serial synchrotron
strategy will improve with the future upgrades at the APS,
which will create a smaller, brighter microfocused beam with
an intensity that is up to two orders of magnitude higher.
These improvements, along with new developments in beam-
line optics and the acquisition of faster frame-readout detec-
tors (e.g. EIGER), will allow X-ray structure determination
from much smaller crystals, possibly on the submicrometre
scale. These improvements will probably improve the resolu-
tion of, for example, crystals of A2AAR using a similar crystal
size (5 mm) from the 3.2 A˚ resolution obtained in this study
to possibly better than 2.5 A˚ resolution. Another interesting
prospect for serial crystallography at synchrotron sources is to
use a broad-bandpass beam such as that at the BioCARS
beamline at the APS. Instead of using a monochromator, a
mirror is used as a low-pass filter, creating a ‘pink beam’,
which can be 500-fold more intense than a monochromated
beam. Preliminary experiments at BioCARS have shown that
serial crystallography data can be collected with a single
100 ps pulse when the APS is operating in hybrid mode or with
four bunches (460 ns) in standard 24-bunch mode (Martin-
Garcia et al., in preparation). However, larger crystals were
required than for this monochromatic study owing to the
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larger beam size at BioCARS compared with GM/CA. The
APS-U will allow the pink beam to be focused more tightly,
enabling serial crystallography on microcrystals. The wider
bandwidth of the pink beam compared with a monochromatic
beam enables the measurement of full reflections, which will
significantly diminish the effect of partiality on the data
(White et al., 2013) and lead to fewer required patterns for a
complete data set.
The study presented here not only demonstrates the current
feasibility of the serial crystallography method for deter-
mining static structures, but also suggests its extension to time-
resolved pump–probe measurements to study light-induced
reactions on millisecond timescales (or faster timescales when
shorter exposure times are available) from microcrystals.
Traditionally, time-resolved crystallography has been
performed on large single crystals mounted on a goniometer
by Laue crystallography using a pink beam (for a review, see
Hajdu & Johnson, 1990). Time-resolved studies at synchro-
trons have always been limited by the pulse length achievable
at these facilities. However, over the past twenty years,
continuous improvements in this technique have allowed a
reduction in the temporal resolution regime from milliseconds
(Genick et al., 1997) to picoseconds (Schotte et al., 2012). In
addition, Laue crystallography has been predominantly
limited to photo-activated reactions, where, unlike diffusion-
based reactions, initiation is homogeneous and rapid.
However, even in photo-induced reactions the size of the
crystals matter since molecules absorb the light as it diffuses
through the crystal, causing a decrease in transmission with
increasing path length. Thus, smaller crystals provide an
advantage, allowing more synchronized reaction initiation
throughout the crystal and requiring decreased pump inten-
sities for maximal reaction initiation. Furthermore, the volume
of the crystals is so small that in practice all molecules within
the crystal can be illuminated by the pump. Owing to the
inherent properties of XFELs, SFX has become an ideal
technique to perform time-resolved experiments (TR-SFX).
Initially, TR-SFX experiments were carried out using the
GDVN liquid injector to deliver the crystals into the beam.
More recently, Nogly and coworkers have demonstrated for
the first time that time-resolved pump–probe serial crystallo-
graphy is also feasible using a high-viscosity injector (Nogly et
al., 2015), allowing a much lower sample consumption.
Therefore, the use of a high-viscosity injector in combination
with a pink beam will also provide an unprecedented view into
the relations between protein structure, dynamics and func-
tion at synchrotron sources.
It is important to note that radiation damage is currently
inevitable when using synchrotron sources. For decades, cryo-
cooling has been used to mitigate the effect of radiation
damage, which is the primary factor limiting the quality of the
structural information that can be obtained from a protein
crystal (Garman, 2010). Several radiation-damage studies
carried out on macromolecular crystals have revealed that the
lifetime of the crystals can be prolonged with an increase in
the beam intensity and a decrease in exposure time (Owen et
al., 2012; Warkentin et al., 2011, 2013). These studies have also
shown that global radiation damage occurs on a timescale of
seconds even with a 100 ms exposure. However, radiation
damage can be notably reduced by outrunning the secondary
and tertiary damage effects (Owen et al., 2012; Warkentin et
al., 2011). The new technique of serial crystallography, in
which each diffraction pattern is from a different crystal,
reduces radiation damage even when measuring crystals at
room temperature at synchrotron sources (Coquelle et al.,
2015; Nogly et al., 2015; Stellato et al., 2014). No radiation
damage was reported in the structures of lysozyme or
bacteriorhodopsin from data sets collected using a liquid
injector (Stellato et al., 2014) or an LCP injector (Nogly et al.,
2015), respectively. The maximum radiation doses were esti-
mated to be 0.3 MGy (Stellato et al., 2014) and 0.7 MGy
(Nogly et al., 2015). However, evidence of specific radiation
damage was observed at the disulfide bridges of the structure
of lysozyme from data sets collected using a raster-scanning
method (Coquelle et al., 2015). Considerably higher doses (3.2
and 29.1 MGy) than the theoretical safe dose limit of 0.3 MGy
(Nave & Garman, 2005) were used. A comparison between
the lysozyme structures when delivering crystals using a jet
(Stellato et al., 2014) and using a fixed target (Coquelle et al.,
2015), which were collected on the same beamline (ID-13 at
the ESRF) under similar conditions, suggests that the radia-
tion doses per crystal are higher when immobilizing crystals in
a solid support and therefore they are more subject to radia-
tion damage. In the study presented here, the LCP injector
was operated at an average flow rate of 100 nl min1, which
provided a constant stream of fresh crystals, so that the
average exposure time per crystal was estimated to be about
30 ms. The average total radiation dose that each single crystal
received was estimated to be only 0.1 MGy, which is lower
than the safe dose limit reported by Garman and coworkers
for room-temperature measurements (Garman &McSweeney,
2007; Nave & Garman, 2005). In fact, we could not detect any
sign of radiation damage on investigating the radiation-
sensitive residues in the structures of either A2AAR or lyso-
zyme, demonstrating that the methods described here enable
data collection at room temperature with minimal radiation
damage.
SMX experiments can also be performed at cryogenic
temperatures to reduce radiation damage by raster scanning
and oscillation of microcrystals mounted into fixed targets
(Gati et al., 2014; Hasegawa et al., 2016; Zander et al., 2015),
allowing crystals to be exposed for longer. Also, since micro-
crystals are rotated during data collection, SMX at cryogenic
temperatures allows complete data to be collected using a
much lower sample consumption compared with that of the
room-temperature-based method. However, SMX at room
temperature offers several advantages over the cryo-based
method, namely (i) room-temperature data collection elim-
inates the need for cryoprotection, which is often difficult and
in some in cases impossible because the cryocooling process
itself can adversely reduce the crystalline order or affect the
protein structure (Fraser et al., 2009, 2011; Keedy et al., 2014),
and (ii) as mentioned above, SMX at room temperature opens
the door to time-resolved pump–probe experiments in the
research papers
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near future. By contrast, SMX using cryocooled crystals is only
limited to the determination of static structures.
Finally, our study also confirms that for strongly diffracting
crystals such as lysozyme, the serial crystallography approach
at current synchrotron sources provides crystal structures of
reasonable quality for crystals of 5 mm and larger. However,
for weakly diffracting crystals with larger unit cells such as
A2AAR or PC, the serial approach at room temperature does
not yield a resolution as high as can be obtained at XFELs or
from cryocooled crystals. Weakly diffracting crystals or crys-
tals with large unit cells will strongly benefit from further
upgrades of synchrotron sources and increased X-ray flux.
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